Background: Second trimester abortions generally account for less number of patients as compared to first trimester abortions as patients generally come earlier as soon as pregnancy is recognized but now days due to advent of USG many cases of fetal anomaly are detected earlier accounting for increasing number of cases of second trimester. Methods: Present study was conducted among patients with pregnancy between 13-20 weeks of period of gestation (to be randomly assigned) after getting approval from institutional ethics committee and informed consent from the patient. Participants were randomly allocated to receive 400 µg of misoprostol either sublingually or intravaginally every six hours for a maximum of 5 doses. The blood pressure, pulse rate & temperature and side effects monitored every 3 hrs. If women in either group failed to abort after 48 hours of initiation of treatment termed as failure. In cases of failure they were given additional doses of sublingual misoprostol till abortion occurred. Primary outcome variable compared was success rate at 48 hours. Secondary outcome variables compared were bleeding patterns, completeness of abortion, induction abortion interval and any side effects. Results: It has been found that vaginal misoprostol 400 micro gm achieved a success rate to 100% in 48 hours, while the success rate was 93.33% with the sublingual route. (P = 0.4915, NS). Conclusions: Thus from our limited study population, we conclude that there is no significant difference in efficacy and complications between the two routes, although a larger cohort is required to get more dependable result.
INTRODUCTION
Safe and legal abortion is considered to be a key intervention for improving women's health and quality of life. 1 In our country a significant number of women practice contraception but Medical Termination of Pregnancy (MTP) is also used to control family size and birth spacing. 2 As a result, an overwhelming proportion of induced abortions (6.7 million annually-an indirect estimate) take place in India 3 and elective termination of pregnancy is considered as a commonly performed gyanecological procedure. 4 Second trimester abortions constitute 10-15% of all induced abortions worldwide, but are related to twothirds of major abortion related complications. 5 During the last decade, medical methods for second trimester induced abortions have has considerably improved and became safe and more accessible.
Although several methods have been tried over the years with varying success, the ideal method for mid-trimester abortion remains elusive, as indicated by the constant search for new methods. [5] [6] [7] [8] [9] Ethacridine lactate has a long history of use in our country and is recommended for use for mid-trimester MTP. 7 However, its use has certain disadvantages such as a longer instillation abortion interval, a higher failure rate and more chances of incomplete abortion. 8, 9 Prostaglandin analogue is commonly used for termination of pregnancy in the second trimester.
Misoprostol is the prostaglandin analogue commonly used, as it is cheap and stable at room temperature. It has been shown to be effective for second trimester termination of pregnancy. 6, 8, 9 Various studies showed that medical abortion is feasible in the first trimester by a combination of mifepristone and repeated dose of misoprostol. Study report also shows that misoprostol in combination with mifepristone is an effective regimen for termination of second trimester abortion up to 20 weeks. [10] [11] [12] Mifepristone is, however, expensive and not approved in most countries of the world. Therefore, it is very important to develop a cost-effective regimen of medical abortion without mifepristone so that women particularly of developing countries can be benefited from its advantages.
In this regard repeated doses of misoprostol have been in use widely. Misoprostol, now a days, is the prostaglandin of choice throughout the world as it has selective mode of action as an E1 prostaglandin and has low rate of sideeffects. Additional benefits of misoprostol are -it is cheap, easily available, stable at room temperature and easy to use. Initially, misoprostol was used orally for medical abortion. However, the use of vaginal misoprostol is becoming a common practice for both medical abortion and cervical priming for other indications. Many clinical trials have found that vaginal administration is more effective than oral administration. 13 This was supported by pharmacokinetic study showing that systemic bioavailability after vaginal administration of misoprostol was three times higher than that after oral administration. 13 However, there has been suggestive evidence showing that absorption through vaginal route is inconsistent and it is not uncommon to find the undissolved misoprostol tablets several hours after vaginal administration. Subsequently a new route of giving misoprostol by sublingual administration has been developed. 14 The sublingual mucosa, being very vascular, serves the purpose of better absorption. Sublingual application also avoids the first pass effect through the liver. The misoprostol tablets, when placed under the tongue, dissolve within 10-15 min. Preliminary data showed that this is a promising route for administration of misoprostol for medical abortion.
The use of sublingual misoprostol for medical abortion has been explored. A pharmocokinetic study has demonstrated that sublingual administration could achieve the peak concentration in the shortest time and has the highest bioavailability. 15 Different routes may be used for administration of misoprostol for second trimester abortion but there is no commonly approved opinion indicating the most effective route. Many studies showed that oral route is the least effective, but between vaginal and sublingual route the opinion still varies regarding which one is better.
Analysing earlier information, we realize that it is important to determine the efficacy, outcome and adverse effects of second trimester medical abortion by intravaginal misoprostol and sublingual misoprostol.
Hypothesis of our study is that sublingual misoprostol is a better alternative to pervaginal misoprostol as a means of second trimester medical termination of pregnancy.
METHODS

Study area
Patients attending gynaecology OPD & family planning clinic in the dept. of obstetrics & gynaecology at NRS medical college & hospital, Kolkata.
Study population
Women attending the hospital for voluntary mid-trimester MTP i.e. 13-20 weeks of pregnancy.
Inclusion criteria
 Women were included in the trial if termination of pregnancy could be made in accordance with the MTP act if India.
 Healthy patients with Hb >10g/d1.
 Patients with period of gestation 13 weeks-20 weeks.
 Patients not allergic to prostaglandins.
Exclusion criteria
 Patients with period of gestation <13 weeks or more than 20 weeks gestation. 
Study period
April 2012 to March 2013.
Study tools
i. Clinical examination report ii.
Drugs -misoprostol iii. Ultrasonography
Sample size
60 women carrying singleton pregnancy were selected for the study.
Sample design
Case selection was done by taking consecutive 60 women & randomly assigning them to either intravaginal misoprostol or sublingual misoprostol in 1:1 ratio.
Study design
Present study was conducted among patients with pregnancy between 13-20 weeks of period of gestation (to be randomly assigned) after getting approval from institutional ethics committee and informed consent from the patient. a) Participants were randomly allocated to receive 400 µg of misoprostol either sublingually or intravaginally every six hours for a maximum of 5 doses.
The blood pressure, pulse rate & temperature and side effects monitored every 3 hours.
If women in either group failed to abort after 48 hours of initiation of treatment termed as failure. In cases of failure they were given additional doses of sublingual misoprostol till abortion occurred. Test for the statistical significance was applied by using Chi square test and Fischer's exact test for analyzing the differences between the two groups (P <0.05 was considered significant).
Primary outcome variables
RESULTS
Maximum No. of patients were in the 20-25 years group. The two groups were comparable with respect to age distribution. Most common indication for termination of pregnancy in both groups was failure of contraception about 80% in the sublingual group and 73% in the pervaginal group. Most of the patients in the sublingual group aborted within 12-24 hours while in the pervaginal group within 12 hrs. There were two failures in the sublingual group although the mean induction -abortion interval in the two groups were comparable with insignificant P value. Within 24 hours 90% of the patients in the vaginal group aborted while in the sublingual group 80% of the patient aborted. In the sublingual group both failures were in the 15-18 weeks group while in the pervaginal group there was 100% success rate in all the three groups P = 0.4915 (NS). In the sublingual group 7 in 28 cases had incomplete evacuation while in the pervaginal group 9 in 30 cases had incomplete evacuation. All cases of incomplete evacuation were followed by check curettage. The deficit in mean Hb% in the sublingual group between day 1 and day 15 was 0.6%. The mean Hb% deficit in the pervaginal group was 0.8 g%. The most common side effect seen in the sublingual group was nausea whereas the most common adverse effect seen in the pervaginal group was fever. All the side effects were comparable in both groups except incidence of fever which was high in the pervaginal group. 26 women out of 30 in the sublingual group preferred the route as they found it more convenient and had less discomfort. 4 of them did not like the route as they did not like the taste of the drug.
In the pervaginal group 12 out of 30 women did not prefer the route due to discomfort while 18 preferred the route as they thought it to be more effective.
DISCUSSION
Second trimester abortions constitute 10-15% of all induced abortions worldwide, but are related to twothirds of major abortion related complications. There is no consensus opinion concerning the most ideal method for termination of second trimester pregnancies. While determining the most appropriate method, cheapness, reduced number of doses and tolerability of its complications are important criteria.
In this study, the two comparing groups are:
Group A: receiving sublingual misoprostol 400 micro gram 6 hourly (upto maximum 5 doses)
Group B: receiving pervaginal misoprostol 400 micro gram 6 hourly (upto maximum 5 doses)
The mean gestational age was 16 ± 2.4 weeks in the sublingual group and 16 ± 2.4 weeks in the pervaginal group (Table 2 ) which corresponds to study by Tang et al. 16 in which the mean gestational age were 15.4 ± 2 weeks and 15.2 ± 1.9 weeks respectively.
The clinical efficacy of pervaginal misoprostol appeared to be slightly superior to sublingual group as shown by success rate at 24 hours which was 90% in the pervaginal group as compared to 80% in sublingual. This corresponds to study done by Tang et al. 16 which also shows success rates of 86% and 72% respectively. Moreover the success rate at the end of 48 hours was also higher in the pervaginal group (100%) as compared to sublingual (93.3%) ( Table 6 ). This is in accordance to study by Tang et al. 16 in which success rate was 91% for sublingual group and 95% for pervaginal group. Also Bhattacharjee et al. 17 found success rate of 79% and 82% respectively in the sublingual and pervaginal groups and was statistically insignificant. Tanha et al. 18 found the success rate of 61% in the pervaginal group and 70% in the sublingual group which was statistically insignificant.
The mean induction -abortion interval was 15.4 hours in sublingual and 14.4 hours in the pervaginal group and was statistically insignificant. This result corresponds with earlier study done by Tang et al. 16 where in the sublingual group the interval was 13.2 hours and in the pervaginal group was 12 hours and the two values were also statistically insignificant. Bhattacharjee et al. 17 found induction -abortion interval to be 14.1 and 14.5 hours in the sublingual and pervaginal groups respectively and was statistically insignificant.
In the sublingual group 75% of the patients had complete abortion as compared to pervaginal group in which 70% of the patients had (Table 7) . This is similar to study by Tang et al. 16 and Tanha et al. 18 The side effects were comparable in both the groups, only significant difference being fever which was significantly higher in the pervaginal group (Table 10 ). This corresponds to study by Tang et al. 16 and by Bhattacharjee et al. 17 The fall in Hb% two groups was comparable and the deficit was statistically insignificant.
Regarding acceptability, the sublingual group was the preferred route of administration (Table 11 ). These findings agreed with previous studies which showed women like to take misoprostol by oral route as it was more comfortable and provided more privacy. 16 In this study we used repeated doses of misoprostol (400 micro gm) in two routes for mid trimester abortion.
It has been found that vaginal misoprostol 400 micro gm achieved a success rate to 100% in 48 hours, while the success rate was 93.33% with the sublingual route (P = 0.4915, NS).
The induction -abortion interval was 14.4 ± 5.3 hours in vaginal route and 15.4 ± 8.08 hours with the sublingual route. (P = 0.5662, NS). So we found that both success rate and induction-abortion interval were comparable for the two routes of administration. Thus both sublingual and vaginal routes are effective for medical abortion in Second trimester.
However more women aborted in 24 hours if vaginal misoprostol was used that is 90% in the vaginal as compared to 80% in the sublingual group (P = 0.4716, NS).
The side effects were similar in both groups except the occurrence of fever which was significantly higher in the vaginal group (P = 0.0159, S). No serious complication was noted in any of the groups.
Regarding acceptability it appeared that sublingual was a more preferable way of administration of the drug.
Thus from our limited study population, we conclude that there is no significant difference in efficacy and
